Law ❯ Litigation ❯ Class Action ❯ Securities Fraud

Lead Plaintiff

Law Firm Files Securities Class Action Against Erasca Over ERAS-0015 Data and IP Claims

The complaint alleges improper comparisons to Revolution Medicines created patent and trade-secret exposure that could undercut Erasca’s public statements about its preclinical candidate.

7 ARTICLES

2mo ago

Eos Energy Investors Face May 5 Deadline to Seek Lead Role in Securities Case

5 ARTICLES

3mo ago

Super Micro Faces Investor Class Actions After DOJ China-Export Indictment

5 ARTICLES

3mo ago

Eos Energy Hit With Securities Class Actions After Revenue Miss Triggers 39% Stock Drop

5 ARTICLES

3mo ago

Monday.com Investors Press Securities Class Action as May 11 Lead-Plaintiff Deadline Nears

11 ARTICLES

3mo ago

Soleno Therapeutics Sued in Federal Securities Class Action Over DCCR Safety Disclosures

8 ARTICLES

3mo ago

Law Firms Mobilize Investors in Eos Energy Securities Suit as May 5 Deadline Nears